How much money will I get from EpiPen class action?
How much money will I get from EpiPen class action?
a $345 million
Pfizer Inc., Meridian Medical Technologies Inc., and King Pharmaceuticals LLC, formerly known as King Pharmaceuticals Inc. — collectively the “Pfizer defendants” — have agreed to a $345 million settlement in an EpiPen class action lawsuit.
How do I know if I won a settlement?
You can find out whether a person bringing a lawsuit won a verdict by inspecting the case file at the courthouse or online. However, if a case settled rather than going to trial, the result might be confidential.
Is EpiPen class action legit?
Mylan said it was pleased with the decision, “as it has always maintained that its actions were completely lawful and pro-competitive.”
What class of drug is EpiPen?
Epinephrine is in a class of medications called alpha- and beta-adrenergic agonists (sympathomimetic agents). It works by relaxing the muscles in the airways and tightening the blood vessels.
What is the settlement agreement with Spike Inc?
Under the settlement agreement, the company will pay a civil penalty to the United States, train its employees on anti-discrimination obligations, and be subject to departmental reporting requirements. On March 31, 2021, the Division signed a settlement agreement with Spike Inc., a construction company headquartered in Sparks, MD.
What is the settlement agreement with LNK?
Under the settlement agreement, the company will pay a civil penalty of $220,000 to the United States. The settlement also requires LNK to train employees on the requirements of the INA’s anti-discrimination provision and subjects it departmental monitoring and reporting requirements for three years.
What is the settlement agreement with esgw?
The settlement agreement requires ESGW to pay a civil penalty of $6,186, train relevant employees about the anti-discrimination requirements of 8 U.S.C. § 1324b, and undergo departmental monitoring for two years.
What is the IER settlement with chemart?
On June 3, 2020, IER signed a settlement agreement with ChemArt, a Rhode Island manufacturing company, resolving claims that the company discriminated against a worker during the employment eligibility verification process and then retaliated against her.
